Christopher K Rayner — ASN Events

Chris Rayner

University of Adelaide, SA, Australia

  • This delegate is presenting an abstract at this event.
  • General Physician
Chris Rayner is a Professor in the School of Medicine, University of Adelaide, and a gastroenterologist at the Royal Adelaide Hospital, South Australia. His major research interest concerns nutrient-gut interactions, including the regulation of gastrointestinal motility, with an emphasis on the role of upper gut function in diabetes. His work aims to develop an understanding of the mechanisms of glucose sensing and incretin hormone release in the gut, and how these can be manipulated for therapeutic gain. He has developed the concept of protein preloads, taken in advance of meals, to initiate gut feedback mechanisms that will lower subsequent postprandial glycaemia in type 2 diabetes. He is a Chief Investigator in an NHMRC Centre of Research Excellence in Translating Nutritional Science to Good Health, based at the University of Adelaide.
Presentations this author is a contributor to:

Comparative effect of intraduodenal and intrajejunal glucose infusion on the gut-incretin axis response in healthy males (#70)

4:00 PM
Tongzhi Wu
ADS Clinical Orals: Gut and Glycaemia

Effects of vildagliptin and/or a whey preload on postprandial glycaemia in patients with type 2 diabetes using metformin (#259)

2:00 PM
Tongzhi Wu
ADS Clinical Poster Prize Presentations

Relationships of ‘Early’ And ‘Late’ Glycaemic Responses With Gastric Emptying During An Oral Glucose Tolerance Test In Subjects With Normal Glucose Tolerance, Impaired Glucose Tolerance And Type 2 Diabetes (#285)

2:00 PM
Chinmay S Marathe
ADS Clinical Poster Viewing: Glycaemia/Monitoring

The glucagon-like peptide-1 (GLP-1) receptor agonist, exenatide, inhibits small intestinal motility, flow, transit and absorption of glucose in health and type 2 diabetes: a randomised controlled trial.  (#71)

4:15 PM
Chinmay S Marathe
ADS Clinical Orals: Gut and Glycaemia

Effects of exenatide on the blood pressure and heart rate responses to intraduodenal glucose in type 2 diabetes (#168)

4:30 PM
Chinmay S Marathe
ADS Clinical Orals: Therapies for Type 2 Diabetes

Increased Capacity for Intestinal Serotonin Release in Obese and Diabetic Humans (#8)

9:00 AM
Richard L Young
ADS Clinical Orals: Obesity

Regional Variation in Expression of Enzymes that Synthesise Incretin Hormones and Glucagon in Lean and Morbidly Obese Humans (#265)

2:00 PM
Richard L Young
ADS Clinical Poster Viewing: Pot Pourri

A low-dose whey protein preload slows gastric emptying and improves post-prandial glycaemia in type 2 diabetes (#69)

3:45 PM
Linda E Mignone
ADS Clinical Orals: Gut and Glycaemia

Effects of exogenous glucagon-like peptide-1 on the blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in healthy older subjects and type 2 diabetes. (#92)

9:15 AM
Laurence G Trahair
ADS Clinical Young Investigator Awards

Intestinal fatty acid sensor (FFAR4) and transporter (CD36) expression are significantly correlated with body mass index, and are not altered by acute fat exposure in lean, overweight or obese humans (#6)

8:30 AM
Nada Cvijanovic
ADS Clinical Orals: Obesity